<DOC>
	<DOC>NCT00913549</DOC>
	<brief_summary>To demonstrate the relative bioequivalency study of dosage forms of Clemastine 2.68 mg tablets.</brief_summary>
	<brief_title>To Demonstrate the Relative Bioequivalency Study of Dosage Forms of Clemastine 2.68 mg Tablets</brief_title>
	<detailed_description />
	<mesh_term>Clemastine</mesh_term>
	<criteria>No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening. Positive test results for HIV or hepatitis B or C. Treatment for drug or alcohol dependence.</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Antihistamine</keyword>
</DOC>